PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (SUBCUTANEOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACEUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALS
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Heparin (Primary)
- Indications Thrombosis
- Focus Biomarker; Pharmacodynamics
- 13 Aug 2012 Biomarkers information updated
- 06 Aug 2012 New trial record